SCHEMBL27180923

SCHEMBL27180923

Cc1cccc(NC(=O)c2ccc(NS(=O)(=O)c3ccc(F)c(Cl)c3)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.64
▸ KMT2A Q03164 6/20 0.64
▸ MAPT P10636 5/20 0.64
▸ ALDH1A1 P00352 4/20 0.64
▸ LMNA P02545 2/20 0.64
▸ GPR27 Q9NS67 5/20 0.59
▸ NPSR1 Q6W5P4 3/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ HTT P42858 2/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ KCNK3 O14649 1/20 0.53
▸ ADORA3 P0DMS8 1/20 0.52
▸ ADORA2A P29274 1/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ ADORA1 P30542 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30926557 1.00 MEN1 (0.64) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL30926485 0.90 MEN1 (0.65) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL27180857 0.90 MEN1 (0.65) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL30926739 0.82 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL27180771 0.82 MEN1 (0.63) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL27179441 0.82 ADORA3 (0.62) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL30926479 0.82 ADORA3 (0.62) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL27181623 0.81 MEN1 (0.62) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL15879829 0.81 SLC10A2 (0.61) MEN1KMT2AMAPTGPR27
SCHEMBL30926873 0.79 MEN1 (0.60) MEN1KMT2AMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 — — EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885MAPT 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback